生命质量量表在药物经济学评价中的选择及应用

Selection and Application of the Quality of Life Scale in Pharmacoeconomics Evaluation

目的:探讨生命质量量表在药物经济学评价中的选择及应用条件。方法:以中国期刊全文数据库(CNKI)为数据源,以"36条目简明量表、SF-36、SF-12量表、SF-6D量表、WHOQOL-100量表、WHOQOL-BREF量表、良好适应状态质量评定量表(QWB),疾病影响程度量表(SIP),诺丁汉健康量表(NHP),欧洲五维健康量表(EQ-5D),健康效用指数(HUI)"为关键词检索,对符合排纳标准的文献进行回顾性分析。结果与结论:通用型生命质量量表中生理方面、心理方面、社会关系、躯体疼痛四个维度重合率最高;通用型生命质量量表较普遍用于评价循环系统疾病患者、内分泌营养和代谢疾病患者、肌肉骨骼系统和结缔组织疾病患者的生命质量。

Objective：To find out the selection and application conditions of the quality of life （QOL）scales in pharmacoeconomics e-valuation.Methods： The author chooses the CNKI library as the data source,“the MOS 36-item short form health survey,SF-36,SF-12 scale,SF-6D scale,WHOQOL-100 scale,WHOQOL-BREF scale,quality of well being index（QWB）, sickness impact profile（SIP）,not-tingham health profile（NHP）,EuroQOL five-dimension questionnaire（EQ-5D）,health utilities index（ HUI）” as the keyword to search papers,and the author do a retrospective study on literature meeting the standard.Results and Conclusion： The physical functioning,psy-chological functioning, social relationship and bodily pain are highly focused in the universal life quality scales; The universal life quality scales usually evaluate the QOL of patients with circulatory system diseases,endocrine-nutritional and metabolic diseases,musculoskeletal system and connective tissue diseases.